310 related articles for article (PubMed ID: 32702368)
41. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of Interventions to Increase Colorectal Cancer Screening Among American Indians and Alaska Natives.
Haverkamp D; English K; Jacobs-Wingo J; Tjemsland A; Espey D
Prev Chronic Dis; 2020 Jul; 17():E62. PubMed ID: 32678062
[TBL] [Abstract][Full Text] [Related]
43. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
[TBL] [Abstract][Full Text] [Related]
44. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
[TBL] [Abstract][Full Text] [Related]
45. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.
Lee YC; Fann JC; Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Hsu CY; Hsu WF; Wu MS; Chen HH
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1332-1340.e3. PubMed ID: 30391435
[TBL] [Abstract][Full Text] [Related]
46. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
[TBL] [Abstract][Full Text] [Related]
47. Persisting Racial Disparities in Colonoscopy Screening of Persons with a Family History of Colorectal Cancer.
Tsai MH; Xirasagar S; de Groen PC
J Racial Ethn Health Disparities; 2018 Aug; 5(4):737-746. PubMed ID: 28812255
[TBL] [Abstract][Full Text] [Related]
48. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
[TBL] [Abstract][Full Text] [Related]
49. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test?
Hamarneh Z; Symonds EL; Kholmurodova F; Cock C
J Gastroenterol Hepatol; 2020 Jun; 35(6):1002-1008. PubMed ID: 31606908
[TBL] [Abstract][Full Text] [Related]
50. Exploring perceptions of colorectal cancer and fecal immunochemical testing among African Americans in a North Carolina community.
Harden E; Moore A; Melvin C
Prev Chronic Dis; 2011 Nov; 8(6):A134. PubMed ID: 22005627
[TBL] [Abstract][Full Text] [Related]
51. Short Term Outcomes of Using Fecal Immunochemical Test for a Pilot Colorectal Cancer Screening Program. A Single Center Study on 3024 Consecutive Patients.
Constantin A; Cazacu I; Ciocârlan M; Constantinescu C; Baltog G; Balahura C; Doraş I; Filip S; Filip G; Panazan I; Piţigoi D; Pirvu V; Turcu F; Copăescu C; Săftoiu A
Chirurgia (Bucur); 2020; 115(4):448-457. PubMed ID: 32876018
[No Abstract] [Full Text] [Related]
52. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
[TBL] [Abstract][Full Text] [Related]
53. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
54. Screening by Total Colonoscopy Following Fecal Immunochemical Tests and Determinants of Colorectal Neoplasia in Japanese Men With Alcohol Dependence.
Mizukami T; Yokoyama A; Yokoyama T; Onuki S; Maruyama K
Alcohol Alcohol; 2017 Mar; 52(2):131-137. PubMed ID: 28182201
[TBL] [Abstract][Full Text] [Related]
55. Low Rate of Cancer Detection by Colonoscopy in Asymptomatic, Average-Risk Subjects with Negative Results From Fecal Immunochemical Tests.
Longstreth GF; Anderson DS; Zisook DS; Shi JM; Lin JC
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2929-2936.e1. PubMed ID: 32007541
[TBL] [Abstract][Full Text] [Related]
56. Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study.
de Klaver W; Wisse PHA; van Wifferen F; Bosch LJW; Jimenez CR; van der Hulst RWM; Fijneman RJA; Kuipers EJ; Greuter MJE; Carvalho B; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
Ann Intern Med; 2021 Sep; 174(9):1224-1231. PubMed ID: 34280333
[TBL] [Abstract][Full Text] [Related]
57. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
[TBL] [Abstract][Full Text] [Related]
58. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
[TBL] [Abstract][Full Text] [Related]
59. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
[TBL] [Abstract][Full Text] [Related]
60. A Multi-Level Fit-Based Quality Improvement Initiative to Improve Colorectal Cancer Screening in a Managed Care Population.
Yu C; Skootsky S; Grossman M; Garner OB; Betlachin A; Esrailian E; Hommes DW; May FP
Clin Transl Gastroenterol; 2018 Sep; 9(8):177. PubMed ID: 30177700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
